Market revenue in 2023 | USD 1,412.5 million |
Market revenue in 2030 | USD 1,783.0 million |
Growth rate | 3.4% (CAGR from 2023 to 2030) |
Largest segment | Cannabis/marijuana |
Fastest growing segment | Cannabis/Marijuana |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Other Drug Types |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Clinical Reference Laboratory, Cordant Health Solutions, ZeOmega, Psychemedics Corp, Millennium HealthCare Inc, Mayo Clinic, Precision Diagnostics, LGC Group, Labcorp Drug Development, Legacy Medical, Drugscan, USDTL |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug of abuse testing services market will help companies and investors design strategic landscapes.
Cannabis/marijuana was the largest segment with a revenue share of 24.27% in 2023. Horizon Databook has segmented the Europe drug of abuse testing services market based on alcohol, cannabis/marijuana, cocaine, opioids, amphetamine & methamphetamine, lsd, other drug types covering the revenue growth of each sub-segment from 2018 to 2030.
Europe held the second-largest share in the drug of abuse testing services market, in 2019. This can be attributed to the increasing prevalence of drug abuse and substance use disorder in key countries, including Germany, the UK, France, Italy, and Spain.
In addition, growing number of initiatives undertaken by several regulatory bodies to increase drug abuse testing is anticipated to create a high demand for drug of abuse testing services.
However, many European countries have forbidden workplace drug testing or random screening, while several countries allow it in safety-critical industries such as energy, transport, and construction. Thus, such unclear regulations related to workplace drug testing in some countries may limit the demand for drugs of abuse testing serveries and hinder the market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe drug of abuse testing services market , including forecasts for subscribers. This continent databook contains high-level insights into Europe drug of abuse testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account